Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: May 2010
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Eli Lilly & Company v. Watson Pharmaceuticals, Inc. et al.2:10-cv-00647; filed May 5, 2010 in the District Court of Nevada • Plaintiff: Eli Lilly & Company• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson…
-
By Sarah Fendrick — In a press release published on April 16, 2010, the U.S. Patent and Trademark Office (USPTO) and the Korean Intellectual Property Office (KIPO) announced the expansion of their existing bilateral Patent Prosecution Highway (PPH) agreement. Under the PPH agreement, an applicant that receives allowable claims from one patent office can…
-
May 11, 2010 – Law Symposium on Intellectual Property (George Washington University Law School, Howrey LLP & Cornerstone Research) – Washington, DC May 18, 2010 – "The Role of Patent Agents in Intellectual Property in the Changing Economy" (Intellectual Property Law Association of Chicago) – Chicago, IL May 20, 2010 – "The Federal Circuit: A…
-
Practising Law Institute (PLI) will be holding its Fundamentals of Patent Prosecution 2010: A Boot Camp for Claim Drafting & Amendment Writing seminar on June 16-18, 2010 in New York, NY and on July 7-9, 2010 in San Francisco, CA. According to PLI's website, the three-day program, which is directed to patent attorneys, litigation attorneys…
-
By Sarah Fendrick — Last week, the U.S. Patent and Trademark Office published a notice in the Federal Register (75 Fed. Reg. 22120) regarding two roundtables that the Office will be holding to obtain public input on methods that can be used to improve patent quality and the methods the Office uses to measure…
-
By Donald Zuhn — On Wednesday, while the biotech industry gathered in Chicago for the 2010 BIO International Convention, Deloitte Touche Tohmatsu (DTT) released a white paper suggesting that the global recession has likely permanently reshaped the life sciences industry. To assess the long- and short-term effects of the recession, and determine whether the…
-
By Kevin E. Noonan — Last week, the Court of Appeals for the Federal Circuit in Therasense Inc. v. Becton Dickinson & Co. issued an order granting plaintiffs' motion for rehearing en banc on the Court's previous affirmance that the patents-in-suit were unenforceable for inequitable conduct. In its order, the Court certified six questions…
-
By Andrew Williams — Last week, in ALZA Corp. v. Andrx Pharms., LLC, the Federal Circuit affirmed the U.S. District Court for the District of Delaware's decision that ALZA's patent related to treating Attention Deficit and Hyperactivity Disorder ("ADHD") was invalid for lack of enablement. ALZA markets the drug Concerta® for the treatment of…
-
By James DeGiulio — After over a decade of suspicion following the death of an 18-year-old patient, gene therapy is experiencing a revival among scientists and drugmakers, according to a recent Bloomberg report ("'Dead as Doornail' Gene Therapy Revival Spurs Genzyme"). Since the patient's death in 1999, scientists have linked many of the safety…
-
The Biotechnology Industry Organization (BIO) is holding its annual BIO International Convention this week at McCormick Place in Chicago, IL. Founded in 1993, BIO is a nonprofit association seeking supportive biotechnology policies on behalf of more than 1,200 biotechnology companies, state and international affiliates, and related organizations, as well as providing business development services for…
Patent Docs 